207 related articles for article (PubMed ID: 19840456)
41. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
Moulopoulos LA; Dimopoulos MA; Kastritis E; Christoulas D; Gkotzamanidou M; Roussou M; Koureas A; Migkou M; Gavriatopoulou M; Eleutherakis-Papaiakovou E; Gika D; Koutoulidis V; Terpos E
Am J Hematol; 2012 Sep; 87(9):861-4. PubMed ID: 22641455
[TBL] [Abstract][Full Text] [Related]
42. Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.
Zang M; Zou D; Yu Z; Li F; Yi S; Ai X; Qin X; Feng X; Zhou W; Xu Y; Li Z; Hao M; Sui W; Deng S; Acharya C; Zhao Y; Ru K; Qiu L; An G
Oncotarget; 2015 Oct; 6(33):34276-87. PubMed ID: 26416457
[TBL] [Abstract][Full Text] [Related]
43. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
[TBL] [Abstract][Full Text] [Related]
44. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
[TBL] [Abstract][Full Text] [Related]
45. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance.
Lloveras E; Solé F; Florensa L; Besses C; Espinet B; Gil M; Pérez-Vila ME; Pedro C; Abella E; Sans-Sabrafen J; Woessner S
Cancer Genet Cytogenet; 2002 Jan; 132(1):25-9. PubMed ID: 11801304
[TBL] [Abstract][Full Text] [Related]
46. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
Nguyen PL; Arthur DC; Litz CE; Brunning RD
Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
[TBL] [Abstract][Full Text] [Related]
47. [Detection of 20q(-) chromosome abnormality in myelodysplastic syndrome by interphase fluorescence in situ hybridization].
Shen YM; Xue YQ; Li JY; Pan JL; Wu YF; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):165-8. PubMed ID: 12744739
[TBL] [Abstract][Full Text] [Related]
48. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
[TBL] [Abstract][Full Text] [Related]
49. Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12.
Zhao L; Khan Z; Hayes KJ; Glassman AB
Ann Clin Lab Sci; 1998; 28(1):51-6. PubMed ID: 9512785
[TBL] [Abstract][Full Text] [Related]
50. Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.
Moore S; Suttle JM; Nicola M
Methods Mol Biol; 2017; 1541():127-142. PubMed ID: 27910020
[TBL] [Abstract][Full Text] [Related]
51. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
[TBL] [Abstract][Full Text] [Related]
52. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
53. Deletion of the retinoblastoma gene in multiple myeloma.
Dao DD; Sawyer JR; Epstein J; Hoover RG; Barlogie B; Tricot G
Leukemia; 1994 Aug; 8(8):1280-4. PubMed ID: 8057662
[TBL] [Abstract][Full Text] [Related]
54. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
55. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
56. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma.
Flactif M; Zandecki M; Laï JL; Bernardi F; Obein V; Bauters F; Facon T
Leukemia; 1995 Dec; 9(12):2109-14. PubMed ID: 8609724
[TBL] [Abstract][Full Text] [Related]
57. Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.
Ha J; Cho H; Lee TG; Shin S; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
Sci Rep; 2022 May; 12(1):8287. PubMed ID: 35585097
[TBL] [Abstract][Full Text] [Related]
58. Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma.
Lee W; Han K; Drut RM; Harris CP; Meisner LF
Genes Chromosomes Cancer; 1993 Jul; 7(3):137-43. PubMed ID: 7687866
[TBL] [Abstract][Full Text] [Related]
59. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Schmidt-Wolf IG; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G
Cancer Genet Cytogenet; 2006 May; 167(1):20-5. PubMed ID: 16682281
[TBL] [Abstract][Full Text] [Related]
60. Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization.
Chang H; Bouman D; Boerkoel CF; Stewart AK; Squire JA
Leukemia; 1999 Jan; 13(1):105-9. PubMed ID: 10049044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
